The pharmaceutical giant Astra Zeneca reports a profit before tax of 1.98 dollars per share in its core business for the second quarter. This is more than the analysts' expected 1.95 dollars, according to Bloomberg's compilation.
The turnover amounted to 12.9 billion dollars, where expectations were slightly above 12.6 billion dollars according to Bloomberg.
